318 related articles for article (PubMed ID: 19131536)
1. Chronic lung allograft rejection: mechanisms and therapy.
Belperio JA; Weigt SS; Fishbein MC; Lynch JP
Proc Am Thorac Soc; 2009 Jan; 6(1):108-21. PubMed ID: 19131536
[TBL] [Abstract][Full Text] [Related]
2. Chronic allograft rejection: epidemiology, diagnosis, pathogenesis, and treatment.
Weigt SS; Wallace WD; Derhovanessian A; Saggar R; Saggar R; Lynch JP; Belperio JA
Semin Respir Crit Care Med; 2010 Apr; 31(2):189-207. PubMed ID: 20354932
[TBL] [Abstract][Full Text] [Related]
3. Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation.
Jaramillo A; Fernández FG; Kuo EY; Trulock EP; Patterson GA; Mohanakumar T
Pediatr Transplant; 2005 Feb; 9(1):84-93. PubMed ID: 15667618
[TBL] [Abstract][Full Text] [Related]
4. Bronchiolitis obliterans syndrome: alloimmune-dependent and -independent injury with aberrant tissue remodeling.
Sato M; Keshavjee S
Semin Thorac Cardiovasc Surg; 2008; 20(2):173-82. PubMed ID: 18707652
[TBL] [Abstract][Full Text] [Related]
5. The number of FoxP3+ cells in transbronchial lung allograft biopsies does not predict bronchiolitis obliterans syndrome within the first five years after transplantation.
Krustrup D; Iversen M; Martinussen T; Schultz HH; Andersen CB
Clin Transplant; 2015 Mar; 29(3):179-84. PubMed ID: 25533723
[TBL] [Abstract][Full Text] [Related]
6. Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal?
Verleden GM; Dupont LJ; Van Raemdonck DE
Eur Respir J; 2005 Feb; 25(2):221-4. PubMed ID: 15684284
[TBL] [Abstract][Full Text] [Related]
7. The contribution of airway ischemia and vascular remodelling to the pathophysiology of bronchiolitis obliterans syndrome and chronic lung allograft dysfunction.
Snell GI; Westall GP
Curr Opin Organ Transplant; 2010 Oct; 15(5):558-62. PubMed ID: 20693899
[TBL] [Abstract][Full Text] [Related]
8. Bronchiolitis obliterans following lung transplantation.
Al-Githmi I; Batawil N; Shigemura N; Hsin M; Lee TW; He GW; Yim A
Eur J Cardiothorac Surg; 2006 Dec; 30(6):846-51. PubMed ID: 17055283
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection.
Vos R; Vanaudenaerde BM; Verleden SE; Ruttens D; Vaneylen A; Van Raemdonck DE; Dupont LJ; Verleden GM
Transplantation; 2012 Jul; 94(2):101-9. PubMed ID: 22461039
[TBL] [Abstract][Full Text] [Related]
10. Lung transplantation: infection, inflammation, and the microbiome.
Nakajima T; Palchevsky V; Perkins DL; Belperio JA; Finn PW
Semin Immunopathol; 2011 Mar; 33(2):135-56. PubMed ID: 21271250
[TBL] [Abstract][Full Text] [Related]
11. The impact of cytolytic therapy on bronchiolitis obliterans syndrome.
Date H; Lynch JP; Sundaresan S; Patterson GA; Trulock EP
J Heart Lung Transplant; 1998 Sep; 17(9):869-75. PubMed ID: 9773858
[TBL] [Abstract][Full Text] [Related]
12. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
[TBL] [Abstract][Full Text] [Related]
13. Bronchiolitis obliterans syndrome complicating lung or heart-lung transplantation.
Belperio JA; Lake K; Tazelaar H; Keane MP; Strieter RM; Lynch JP
Semin Respir Crit Care Med; 2003 Oct; 24(5):499-530. PubMed ID: 16088570
[TBL] [Abstract][Full Text] [Related]
14. Immunologic consequences of transplantation.
Keenan RJ; Zeevi A
Chest Surg Clin N Am; 1995 Feb; 5(1):107-20. PubMed ID: 7743142
[TBL] [Abstract][Full Text] [Related]
15. Bronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation.
Weigt SS; DerHovanessian A; Wallace WD; Lynch JP; Belperio JA
Semin Respir Crit Care Med; 2013 Jun; 34(3):336-51. PubMed ID: 23821508
[TBL] [Abstract][Full Text] [Related]
16. Acute rejection and humoral sensitization in lung transplant recipients.
Martinu T; Chen DF; Palmer SM
Proc Am Thorac Soc; 2009 Jan; 6(1):54-65. PubMed ID: 19131531
[TBL] [Abstract][Full Text] [Related]
17. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection.
Bharat A; Narayanan K; Street T; Fields RC; Steward N; Aloush A; Meyers B; Schuessler R; Trulock EP; Patterson GA; Mohanakumar T
Transplantation; 2007 Jan; 83(2):150-8. PubMed ID: 17264811
[TBL] [Abstract][Full Text] [Related]
18. Obliterative bronchiolitis following lung transplantation: from old to new concepts?
Verleden GM; Vos R; De Vleeschauwer SI; Willems-Widyastuti A; Verleden SE; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM
Transpl Int; 2009 Aug; 22(8):771-9. PubMed ID: 19490538
[TBL] [Abstract][Full Text] [Related]
19. Are we near to an effective drug treatment for bronchiolitis obliterans?
Verleden GM; Vos R; Dupont L; Van Raemdonck DE; Vanaudenaerde BM; Verleden SE
Expert Opin Pharmacother; 2014 Oct; 15(15):2117-20. PubMed ID: 25154562
[TBL] [Abstract][Full Text] [Related]
20. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome.
Daud SA; Yusen RD; Meyers BF; Chakinala MM; Walter MJ; Aloush AA; Patterson GA; Trulock EP; Hachem RR
Am J Respir Crit Care Med; 2007 Mar; 175(5):507-13. PubMed ID: 17158279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
